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Objectives This study sought to assess the vascular function in patients with chronic total coronary
occlusions (CTO) immediately after successful percutaneous recanalization and its relation with the
pre-existing collateral circulation.
Background CTOs represent a long-acting occlusion of a coronary vessel, in which the progressively
developed collateral circulation may limit ischemia and symptoms. However, it is unknown if the
coronary segment distal to the occlusion has a preserved vascular function.
Methods We prospectively enrolled 19 consecutive patients, after percutaneous coronary interven-
tion of a CTO. Luminal diameter, measured by quantitative coronary angiography, and coronary
blood ﬂow at level of epicardial coronary artery distal to the treated CTO was assessed before and
after administration of acetylcholine (Ach), adenosine, and nitroglycerin (NTG). Collaterals were as-
sessed angiographically by grading of Rentrop and of collateral connections (CC1: threadlike contin-
uous connection; CC2: side branch–like connection).
Results Overall, Ach and adenosine caused coronary artery vasoconstriction (p  0.001 and p  0.004,
respectively), whereas NTG failed to induce vasodilation (p  0.084). Coronary blood ﬂow signiﬁ-
cantly decreased with Ach (p  0.005), signiﬁcantly increased with NTG (p  0.035), and did not
change with adenosine (p  0.470). Patients with CC2 collaterals (n  8) had less vasoconstriction
response and reduction in coronary blood ﬂow after Ach (p  0.005 and p  0.008, respectively),
and better vasomotor response to NTG (p  0.029) than patients with CC1 collaterals (n  11).
Conclusions Signiﬁcant endothelial and smooth muscle dysfunction is present in the distal seg-
ments of successfully recanalized CTOs, and that seems to be more pronounced in the presence of
a low grading of collateral circulation. (J Am Coll Cardiol Intv 2012;5:170–8) © 2012 by the
American College of Cardiology Foundation
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171The endothelium is a key regulator of vascular physiology,
and a damaged or dysfunctional endothelium is an initiator
of vascular atherosclerosis (1,2). Endothelial dysfunction is a
predictor of coronary events in patients with coronary artery
disease and is also associated with short-term coronary graft
performance (1,3).
See page 179
Severe endothelial dysfunction has been previously dem-
onstrated in the infarct-related occluded coronary artery
during the early phase after thrombotic occlusion (4). Compared
ith infarct-related occlusion, chronic total occlusions
CTOs), defined as obstructions of a native coronary artery
f at least 3 months’ duration, with no luminal continuity
nd a Thrombolysis In Myocardial Infarction (TIMI) flow
rade 0, have a totally different pathological substrate
sudden thrombotic occlusion vs. slow fibrocalcific occlu-
ion) and a different pattern of collateral circulation devel-
pment (5). In particular, whereas in an acute thrombotic
cclusion collaterals develop suddenly or if pre-existing can
e acutely recruited and may not be able to restore adequate
lood requirements, in chronic occlusion, they develop
radually during the progression of a coronary lesion to a
TO, limiting ischemia and symptoms (6,7). At present, there
re no available data on whether endothelial function is abnormal
n the coronary segment distal to a CTO or whether the presence
f collaterals is able to limit it.
The aims of our study were: 1) to assess endothelial and
mooth muscle cells’ function distal to a CTO immediately
fter successful recanalization by percutaneous coronary inter-
ention (PCI); and 2) to explore its relationship with the
re-existing collateral circulation.
ethods
Population. From January 2009 to December 2009, all
onsecutive patients, who underwent successful recanaliza-
ion of a CTO by PCI, were screened in a single center and
ere prospectively included in the study. The duration of
he occlusion was defined on the basis of a previous
ngiogram, the date of a prior myocardial infarction, or the
nset of symptoms (5,8). All enrolled patients were symp-
omatic for angina and/or had documented ischemia/
iability by noninvasive tests in myocardial regions supplied
y the CTO (9), and a minimum of 20 mm of distal vessel
menable for endothelial function testing. For patients with
ilent ischemia, a functional test, showing ischemia in the
yocardial territory supplied by the CTO, was required to
ndicate the PCI procedure. Patients with contraindications
o dual antiplatelet therapy, known or suspected infections,
nd/or diseases that may have possible effects on inflamma-
ion were excluded. All patients received the Resolute
otarolimus-eluting stent (Medtronic, Santa Rosa, Califor-ia) to cover all dilated segments. All clinical and angio-
raphic data were prospectively recorded. All patients gave
heir written informed consent to participate in the study.
he ethical committee of the hospital approved the protocol.
Angiographic assessment of collaterals. In all angiographic
diagnostic studies, the views with the least foreshortening of
the collateral connection were selected for analysis. The
angiograms were analyzed as follows:
1. Collateral filling of the recipient artery was assessed
according to the Rentrop classification. Briefly, Ren-
trop grade is categorized as follows: 0 —no filling of
any collateral vessels; 1—filling of side branches of
the epicardial segment; 2—partial filling of the epi-
cardial artery by collateral vessels; and 3— complete
filling of the epicardial artery by collateral vessels
(10) (Fig. 1).
2. The size of the collateral connection (CC) diameter
was semiquantitatively assessed by 3 grades: CC0—no
continuous connection be-
tween donor and recipient
artery; CC1—continuous,
threadlike connection; and
CC2— continuous, small
side branch–like size of
the collateral through its
course. To provide a size
estimate, the collaterals
were measured, as previ-
ously shown, with an elec-
tronic caliper on enlarged
still images: CC1 collater-
als had diameters 0.3
mm and CC2 0.4 mm
(11,12) (Fig. 1).
Two independent observers, blinded to clinical charac-
eristics and post-PCI angiographic response to vasodilators
erformed this grading. In case of disagreement, a consen-
us was reached by a third independent observer.
Assessment of endothelial function in the CTO vessel. Long-
acting oral vasoactive drugs were discontinued24 h before
the study. Endothelium-dependent and -independent cor-
onary vasomotion was studied as previously described
(13,14). After successful recanalization of the CTO and
implantation of stent, a 0.014-inch Doppler wire with a
12-MHz piezoelectric transducer mounted on the tip
(FlowWire, Volcano, Therapeutics Inc., Rancho Cordova,
California) was advanced into the recanalized coronary
artery, approximately 5 to 10 mm distal to the distal edge of
the implanted stent. As the stents covered the entire injured
segment during the PCI, the endothelial function study was
performed distal to the stents in a noninjured segment. The
electrocardiogram and arterial blood pressure were contin-
Abbreviations
and Acronyms
Ach  acetylcholine
Ade  adenosine
APV  average peak velocity
CBF  coronary blood flow
CC  collateral connection
CTO  chronic total
occlusion
NTG  nitroglycerin
PCI  percutaneous
coronary intervention
TIMI  Thrombolysis In
Myocardial Infarctionuously recorded.
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172An infusion microcatheter (Finecross, Terumo Corpora-
tion, Tokyo, Japan) was advanced over a guidewire and
placed at least 15 mm proximal to the tip of the flow wire,
after which the guidewire was removed. After obtaining a
stable Doppler signal, saline solution was infused through
the microcatheter for 1 min to determine the baseline
vasomotion tone. This was followed by a baseline angio-
gram, taken in the 2 orthogonal projections that best
showed the artery, without the overlapping of side branches
and with minimal foreshortening. From the Doppler flow
velocity spectra, the average peak velocity (APV) was
calculated as the time-averaged value of the instantaneous
peak velocity over 2 consecutive cardiac cycles. A 2 min,
selective infusion of acetylcholine (Ach) (106 mol/l), a
20-g bolus of adenosine (Ade) and a 200-g bolus of
itroglycerin (NTG) were administered. A washout period
f at least 5 min between the administration of each drug
as mandatory. At peak velocity, blood flow velocity in
Figure 1. Examples of CC and Rentrop Grades
White arrows indicate the collateral connection (top) or the distal vessel fulﬁesponse to each vasoactive substance was measured andtudy angiograms in identical projections as to those per-
ormed at baseline were recorded (Fig. 2).
Offline quantitative coronary angiography analysis was
erformed by 1 independent and blinded observer (Cardi-
lysis, Rotterdam, the Netherlands) using the CAAS system
Pie Medical, Maastricht, the Netherlands). Calibration of
he system was based on dimensions of the guide catheter
lled with contrast medium. The mean luminal diameter
average of the 2 orthogonal projections) was determined
fter infusion of each substance in the coronary segment
istal to the edge of the stents and to the tip of the flow
ire. Intraobserver variability showed a correlation coeffi-
ient (R2) of 0.97. Changes in diameter were calculated as
percentage of change in mean luminal diameter compared
with the baseline measurement.
We estimated the volumetric coronary blood flow (CBF)
before and after administration of vasodilators according to
the validated formula: cross-sectional area  APV  0.5
collaterals (bottom). CC  collateral connection.lled by(15). For the cross-sectional area of the epicardial vessel, we
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173used the luminal diameter at baseline and after the infusion
of Ach, Ade, and NTG. Changes in flow volume have been
calculated as percentage of change in mean flow volume
compared with the baseline measurement.
In experimental models and in humans, ACh is known to
cause endothelium-dependent vessel relaxation (16,17);
therefore, paradoxical vasoconstriction after its infusion was
used as an indicator of endothelial dysfunction (13).
Statistical analysis. Continuous data are expressed as mean 
D or median (interquartile range), according to their
ormal or not normal distribution, whereas categorical data
re expressed as percentages and counts. Analysis of the
ormality of continuous variables was tested using the
olmogorov-Smirnov test. Changes of parameters from
aseline to post-administration of the various vasoactive
rugs were evaluated by Wilcoxon test for paired data.
ifferences between 2 groups were analyzed by the Mann-
hitney U test. No adjustments were made for multiple
omparisons. A 2-sided p value of 0.05 indicated statis-
Figure 2. Study Protocol
Protocol used in the evaluation of the endothelial function. Lumen diameter a
tion (PCI) (baseline) and after sequential infusion of acetylcholine (Ach) and bo
datory between administrations of each vasoactive substance. Angio  angiog
Figure 3. Flow Chart of Screening and Enrollment of the Patients in the StCABG  coronary artery bypass graft; CTO  chronic total occlusion; PCI  percutanical significance. Statistical analyses were performed by the
se of SPSS software (version 16.0. SPSS Inc., Chicago,
llinois).
esults
Baseline and procedural characteristics. A total of 19 pa-
tients were enrolled in the study (Fig. 3). Table 1 shows the
baseline clinical and procedural characteristics. All patients
were on dual antiplatelet therapy (acetylsalicylic acid 
clopidogrel). Prior PCI were all performed in a non-CTO
vessel, without evidence of restenosis at the time of the
CTO-PCI. Patient with a left internal mammary artery on
the left anterior descending artery had a CTO of the right
coronary artery. Out of the 7 patients having a previous
myocardial infarction, only 3 had had it in the same territory
of the CTO. Of note, only 1 patient exhibited necrosis in
the same region of the CTO, but with residual viability by
means of functional testing.
w evaluation were performed at the end of percutaneous coronary interven-
of adenosine and nitroglycerin (NTG). A washout interval of 5 min was man-nd ﬂo
lusesudyeous coronary intervention.
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174Assessment of collateral pathways. Collateral connection
rade CC2 was observed in 8 patients (42%) and CC1 in 11
atients (58%). Conversely, Rentrop grade was scored as 3
n 6 patients (31%), as 2 in 7 patients (38%), and as 1 in the
Table 1. Baseline Clinical Characteristics (N  19)
Age, yrs 59.9 8.5
Male 17 (89)
Coronary risk factors
Hypertension 15 (79)
Dyslipidemia 10 (52)
Diabetes 6 (31)
Smoke 4 (21)
Stable angina 13 (68)
Silent ischemia 6 (32)
Previous MI 7 (37)
LV ejection fraction, % 55.3 13.7
Location of previous MI
Anterior 2 (10)
Lateral 2 (10)
Inferior 3 (15)
Previous PCI 6 (31)
Location of previous PCI
LAD 4 (21)
LCX 0
RCA 2 (10)
Previous CABG 1 (5)
IMA on LAD 1 (5)
Renal impairment 3 (15)
Localization of CTO
LAD 8 (42)
LCX 2 (10)
RCA 9 (48)
Time of occlusion, months 11.7 8.3
Lesion length, mm 16.1 7.0
Number of stent(s) implanted 1.9 0.9
Implantation pressure, atm 16.9 2.2
Diameter of stent implanted, mm 2.7 0.2
Length of stent implanted, mm 38.5 27.4
CK post-procedure, IU/l 44.45 33.15
Contrast used, ml 177.9 63.0
Time procedure, min 98.0 25.9
Fluoroscopic time, min 24.2 12.2
Therapy
ASA 19 (100)
Clopidogrel 19 (100)
Beta-blockers 16 (84)
ACE-I/ARB 18 (94)
Statins 17 (89)
Values are mean SD or n (%).
ACE-I angiotensin-converting enzyme inhibitor; ARB angiotensin receptor blocker; ASA
acetylsalicylic acid; CABG  coronary artery bypass graft; CK  creatine kinase; IMA  internal
mammary artery; IU  international unit; LAD  left anterior descending artery; LCX  left
circumflex artery; LV  left ventricle; MI  myocardial infarction; PCI  percutaneous coronary
intervention; RCA right coronary artery.emaining 6 patients (31%). There was no correlation between (he CC grading and the Rentrop grading (r  0.13, p 
.590). No differences in clinical and procedural variables
ere observed between the patients, when stratified accord-
ng to Rentrop (Rentrop 3 vs. Rentrop 3) or CC grades
CC2 vs. CC1) (Online Table 1 and Online Table 2).
The interobserver variability yielded a good concordance for
entrop and CC grades (kappa  0.74 and 0.91, respectively).
Overall coronary vasomotion and blood ﬂow evaluation.
Overall, there was a significant reduction in mean luminal
diameter with Ach (p  0.001) and Ade (p  0.004),
whereas no significant increase was observed with NTG
(p  0.084). Of note, 18 patients demonstrated vasocon-
striction response after Ach (45 20% of change in mean
uminal diameter), whereas 1 patient did not exhibit change
n mean luminal diameter (0.2% of change). Conversely,
nly 2 and 3 patients experienced vasodilation following
dministration of Ade and NTG, respectively (Table 2).
APV did not change after infusion of Ach (p  0.172),
hereas it significantly increased after Ade and NTG
dministration (p  0.02 and p  0.001, respectively).
Eventually, CBF decreased after infusion of Ach (p 
.005), increased after infusion of NTG (p  0.035), and
id not change after infusion of Ade (p  0.470).
Coronary vasomotion according to collateral pathways. No
differences in terms of baseline mean luminal diameter,
APV, or CBF were found between patients with CC2 versus
CC1 and Rentrop 3 versus Rentrop 3 (Tables 3 and 4).
Patients with a CC2 grade showed significantly less
reduction in mean luminal diameter after infusion of Ach
(p 0.005) and greater increase in mean lumen diameter to
NTG (p  0.029) as compared to patients with a CC1
grade. No difference was found after infusion of Ade (p 
0.491) (Fig. 4).
Patients with a Rentrop grade 3, compared with patients
with Rentrop grade 3, also exhibited a lower reduction in
mean luminal diameter after infusion of Ach (p  0.002).
At the same time, they showed a trend toward a smaller
change in mean luminal diameter in response to NTG (p 
0.143) compared with the other group. No difference was
found after infusion of Ade (p  0.773) (Fig. 4).
Coronary blood ﬂow according to collateral pathways. APV
was not different in patients with CC2 grade compared with
those with CC1 grade after acetylcholine (p  0.573), Ade
(p  0.414), or NTG infusion (p  0.662). No differences
ere found categorizing the patients also according to
entrop 3 versus 3 (Tables 3 and 4).
Patients with CC2 exhibited a smaller reduction in CBF
fter Ach (p  0.008), compared with patients with CC1.
CBF responses to Ade and NTG were similar between CC2
and CC1 (Fig. 5). Patients with Rentrop 3 exhibited smaller
reduction in CBF after infusion of Ach (p  0.008) and
greater increase after Ade (p  0.188) and NTG
(p  0.036) compared with patients with Rentrop grade 3
Fig. 5).
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175Discussion
The major findings of this study are: 1) the coronary
segment distal to a successfully treated CTO exhibits
endothelial and smooth muscle cells dysfunction by assess-
ment immediately after percutaneous recanalization; 2) this
translates in an impaired flow-mediated vasodilation after
PCI that compromises a complete restoration of antero-
grade blood flow; 3) patients with a pre-procedural low-
graded collateral circulation appear to have worse endothe-
lium/smooth muscle cells dysfunction than patients with
high graded collateral circulation; 4) relative changes in
coronary blood flow seem also to be correlated to the grade
of pre-procedural collateral circulation.
Classically, endothelial dysfunction represents the first
step of atherosclerosis (2,18) and it has been extensively
studied in various types of coronary lesions (3,4). Coronary
chronic total coronary occlusions have per definition at least
3-months duration; thus, the vascular segment distally to
Table 2. Angiographic Data of Vasomotor Response
Baseline
(n  19)
Ach
(n  19)
Mean luminal diameter, mm 1.82 (1.49–2.40) 1.03 (0.67–1.50)
Average peak velocity, cm/s 21.5 (17.0–30.0) 26.5 (19.0–33.0)
Coronary blood ﬂow, ml/min 19.8 (9.7–34.7) 4.69 (2.76–17.8)
Values are median (interquartile range).
Ach Acetylcholine; Ade adenosine; IQR interquartile range; NTG nitroglycerin.
Table 3. Angiographic Data of Vasomotor Response According
to the CC Grade
CC2 Grade
(n  8)
CC1 Grade
(n  11) p Value
Baseline
Mean luminal diameter, mm 1.83 (1.58–2.03) 1.77 (1.43–2.47) 0.852
Average peak velocity, cm/s 23.5 (14.0–53.0) 21.5 (18.0–23.0) 0.950
Coronary blood ﬂow, ml/min 24.3 (11.0–44.2) 19.8 (9.3–25.8) 0.491
Ach
Mean luminal diameter, mm 1.45 (1.26–1.50) 0.70 (0.56–0.98) 0.020
Average peak velocity, cm/s 28.5 (24.0–49.0) 25.5 (17.0–31.0) 0.414
Coronary blood ﬂow, ml/min 17.6 (11.1–24.2) 3.3 (1.6–4.7) 0.059
Ade
Mean luminal diameter, mm 1.61 (1.18–1.90) 1.52 (0.80–1.84) 0.573
Average peak velocity, cm/s 43.0 (36.0–88.0) 39.0 (27.5–52.5) 0.573
Coronary blood ﬂow, ml/min 30.1 (18.2–35.8) 18.0 (5.56–33.5) 0.491
NTG
Mean luminal diameter, mm 1.89 (1.51–2.30) 1.64 (1.14–1.96) 0.228
Average peak velocity, cm/s 41.0 (29.0–63.0) 40.0 (31.0–41.0) 0.662
Coronary blood ﬂow, ml/min 42.1 (22.5–55.8) 20.3 (12.7–30.3) 0.181
Values are median (interquartile range).CC collateral connection; other abbreviations as in Table 2.the occlusion usually become supplied by a collateral circu-
lation, which can more or less restore the blood require-
ments of the collateral-dependent myocardium and at the
same time probably contribute to maintain a normal re-
gional myocardial function (8). Our analysis showed, how-
ever, that an endothelial dysfunction is present in this kind
of lesion immediately after the recanalization, as suggested
by an intense vasoconstriction response to Ach in the
vascular segment distal to the occlusion. The same vascular
segment exhibits also a smooth muscle cells dysfunction,
with an inability to vasodilate after administration of Ade or
NTG. Adenosine and nitrates have vasodilatory effect on
smooth muscle cells via different mechanisms. Adenosine is
a potent arteriolar dilator via stimulation of A2 receptors of
smooth muscle cells. Its main effect in the coronary circu-
lation is a drastic decrease of arteriolar resistance, leading to
an increase of CBF and, in return, to flow-mediated dilation
of epicardial vessels. Conversely, nitrates have a direct
vasodilatory effect on smooth muscle cells (19–21). The
de
19)
NTG
(n  19)
p Value
Ach vs.
Baseline
Ade vs.
Baseline
NTG vs.
Baseline
.90–1.88) 1.74 (1.45–2.10) 0.001 0.004 0.084
3.0–60.0) 40.0 (30.0–42.0) 0.172 0.022 0.001
.6–25.8) 26.3 (17.4–42.7) 0.005 0.470 0.035
Table 4. Angiographic Data of Vasomotor Response According to
Presence of Rentrop 3
Rentrop 3
(n  6)
Rentrop <3
(n  13) p Value
Baseline
Mean luminal diameter, mm 1.84 (1.56–2.28) 1.78 (1.50–2.40) 0.733
Average peak velocity, cm/s 20.0 (15.5–46.5) 21.5 (17.0–30.0) 0.945
Coronary blood ﬂow, ml/min 24.1 (12.234.9) 19.8 (8.9–25.9) 0.635
Ach
Mean luminal diameter, mm 1.70 (1.14–2.04) 0.78 (0.64–1.26) 0.054
Average peak velocity, cm/s 28.0 (24.0–66.0) 25.5 (15.0–33.0) 0.374
Coronary blood ﬂow, ml/min 21.0 (14.4–27.2) 3.4 (1.8–4.9) 0.024
Ade
Mean luminal diameter, mm 1.59 (1.26–1.86) 1.52 (0.85–1.90) 0.945
Average peak velocity, cm/s 51.5 (43.0–75.0) 35.5 (22.0–45.0) 0.106
Coronary blood ﬂow, ml/min 32.6 (23.8–41.6) 18.0 (4.55–30.6) 0.240
NTG
Mean luminal diameter, mm 1.94 (1.60–2.35) 1.64 (1.35–2.02) 0.240
Average peak velocity, cm/s 41.0 (34.5–63.5) 40.0 (30.0–42.0) 0.539
Coronary blood ﬂow, ml/min 44.1 (32.6–50.7) 20.3 (8.0–30.5) 0.076
Values are median (interquartile range).A
(n 
1.52 (0
43.0 (3
24.4 (8Abbreviations as in Table 2.
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176absence of vasodilation following these drugs may be related
to a dysfunction in both mechanisms. Nevertheless, the
enhanced vasoconstrictor response to Ach indicates the
presence of some preserved vasoreactivity of the smooth
muscle cell layer.
Interestingly, we observed a somewhat “paradoxical” re-
sponse after administration of Ade, with vasoconstriction of
the artery, which cannot be explained only by impaired
Figure 4. Changes in Mean Lumen Diameter Between the Various Groups
Relative changes in mean luminal diameter from baseline following
administration of Ach, adenosine, and NTG for CC2 versus CC1 (top) and
Rentrop 3 versus Rentrop 3 (bottom). Abbreviations as in Figures 1 and 2.endothelial-dependent flow-mediated dilation and may
support direct constriction of smooth muscle cells. Previ-
ously in an animal model of CTOs, Heaps et al. (22)
demonstrated the selective impairment of cyclic adenosine
monophosphate–dependent vasodilation with Ade, which
was partially restored by exercise training. In particular, they
found that the vasodilation was not impaired by adminis-
Figure 5. Changes in CBF Between the Various Groups
Relative changes in coronary blood ﬂow (CBF) from baseline following
administration of Ach, adenosine, and NTG for CC2 versus CC1 (top) and
Rentrop 3 versus Rentrop 3 (bottom). Abbreviations as in Figures 1 and 2.tration of forskolin, a membrane-permeant, receptor-
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177independent vasodilator that stimulates adenyl cyclase di-
rectly (23). Similarly, Sellke et al. (24) found in a dog model
an impaired relaxation to adenosine diphosphate in
collateral-dependent coronary microvessels compared with
control subjects. These findings in animal models can
suggest either a selective damage/down-regulation of Ade
receptors or a defective access of receptor agonist/associated
G proteins to the intracellular pools of adenyl cyclase in
coronary smooth muscle cells distal to the occlusion, which
may in turn activate different intracellular pathways finally
causing vasoconstriction. Another possible explanation of
this “paradoxical” response to Ade is that the endothelial
dysfunction after Ach administration was so intense to mask
the flow-mediated dilation after Ade administration, further
supporting the intense vascular dysfunction present in the
vascular segment distal to a CTO immediately after recan-
alization. These hypotheses need to be confirmed in a larger
study.
Our study analyzed also the blood flow responses after
administration of these vasoactive drugs in CTO after
recanalization. In particular, infusion of Ach was not able to
increase the CBF, due to its marked vasoconstriction effect
on epicardial vessels, but conversely it provoked a significant
decrease in CBF. Adenosine and NTG correctly increase
the APV, but a significant increase in coronary blood flow
was detected only after NTG. The lack of flow-mediated
dilation to Ade in presence of a correct increase in flow
velocity might lead to an elevation in shear stress and could
help to identify treated-CTO with high risk of restenosis
(25). In clinical practice, many CTO cases show an im-
provement in distal vessel diameter in the long term. The
fact that post-PCI angiography is performed in a context of
severe endothelial dysfunction, as shown in our analysis,
with a hypothetic positive, flow-mediated vessel remodel-
ing, once the endothelial function improves under nonisch-
emic and anterograde flow conditions, could explain this
enlargement in distal vessel diameter. However, further
studies are needed to confirm this hypothesis.
As the degree of collateral circulation in CTO is ex-
tremely variable, we sought to analyze the vasomotor and
blood flow responses in relation to the degree of pre-
procedural collateral circulation. This was evaluated using
both qualitative and semiquantitative indexes, such as Ren-
trop and CC scores, respectively. In particular, the angio-
graphic grading of the CC has been shown to be closely
associated with invasively determined parameters of collat-
erals’ hemodynamics. This allowed us to optimally differ-
entiate collaterals according to their functional capacities
without excessively prolonging the CTO-PCI for hemody-
namic measurement (12). Conversely, Rentrop grade showed
only a weak correlation with invasive parameters of collateral
function and, as it is based on a qualitative assessment, has
a high interobserver variability (12,26). In line with previous
reports, we found a weak correlation between CC andRentrop grades (12). The endothelial and smooth muscle
cells dysfunction appeared to be greater in patients with a
baseline CC1 grade than in patients with a baseline CC2
grade. The CC2 grade patients were also found to have
smaller decreases in CBF after infusion of Ach compared
with CC1 grade patients, which is suggestively due to a
higher recruitment of collateral vessels. Despite the limited
number of patients, our findings suggest a causal relation-
ship between CTO collateral circulation and vasomotor
function of the vessel distal to the occlusion. Future studies
should address whether the impaired vasomotor function is
really a cause or an effect of the pre-existing collateral
circulation of a CTO. Another interesting hypothesis to test
would be whether the presence of a previous myocardial
infarction in the same territory of the CTO could addition-
ally influence the vascular function distal to the CTO. In
our analysis, only 1 patient exhibited necrosis distal to the
CTO, so that any statistical comparison would have been
meaningless.
Study limitations. The main limitations in our study relate
o the small number of patients included. For these reasons,
ur findings should be considered as exploratory and need to
e confirmed in larger studies. In addition, we did not
ollect any data about the non-CTO vessel and did not
nclude a control group. Time of occlusion definition could
e imprecise in such a small population and in the absence
f serial angiograms.
The collateral function was not assessed invasively
e.g., collateral flow index) to not prolong excessively the
rocedural time. The CC angiographic grading, however,
as previously been shown to be closely associated with
nvasively determined parameters of collaterals hemody-
amics (12).
We used only 1 dose of Ach (106), which is the highest
ose used in humans to evaluate the maximal endothelium-
ependent vasomotor response (4,14). Coronary flow reserve
as not calculated, as epicardial vessel sizes were not constant
fter the infusion of Ade, as previously indicated (27).
onclusions
Our study demonstrates that in the coronary segment distal
to a CTO, there is an impairment of endothelial and
smooth muscle cell function, which seems to be most
notable in the presence of low-graded collateral circulation.
Larger studies are required to determine the clinical signif-
icance of these findings.
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APPENDIX
For supplementary information on Rentrop and CC grades, please see the
online version of this article.
